April 15, 2026
CellCarta offers a full range of validated genomic assays. With sites accredited by CAP and CLIA certifications, we provide the highest standard of quality. Our team continually develops new biomarker assays and has experience with several commercial assays. Contact us for any custom development.
You might also be interested by
Brochures & Infographics
Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq
June 15, 2026
More infoPosters
Advancing B-Cell Monitoring in B-Cell-Depleting Therapies for Autoimmune Disorders
June 8, 2026
More infoUncategorized
Accelerating spectral flow cytometry assay development for clinical trials with a flexible panel design
June 8, 2026
More info